Global Lung Cancer Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Lung Cancer Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Chemotherapy
1.2.5 Radiation Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Lung Cancer Therapeutics Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Non-Small Cell Lung Cancer (NSCLC)
1.3.3 Small Cell Lung Cancer (SCLC)
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Lung Cancer Therapeutics Market Size (2017-2028)
2.2 Lung Cancer Therapeutics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Lung Cancer Therapeutics Market Size by Region (2017-2022)
2.4 Global Lung Cancer Therapeutics Market Size Forecast by Region (2023-2028)
2.5 Global Top Lung Cancer Therapeutics Countries Ranking by Market Size
3 Lung Cancer Therapeutics Competitive by Company
3.1 Global Lung Cancer Therapeutics Revenue by Players
3.1.1 Global Lung Cancer Therapeutics Revenue by Players (2017-2022)
3.1.2 Global Lung Cancer Therapeutics Market Share by Players (2017-2022)
3.2 Global Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Lung Cancer Therapeutics Revenue
3.4 Global Lung Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Therapeutics Revenue in 2021
3.5 Global Lung Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Lung Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Lung Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Lung Cancer Therapeutics Breakdown Data by Type
4.1 Global Lung Cancer Therapeutics Historic Revenue by Type (2017-2022)
4.2 Global Lung Cancer Therapeutics Forecasted Revenue by Type (2023-2028)
5 Global Lung Cancer Therapeutics Breakdown Data by Application
5.1 Global Lung Cancer Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Lung Cancer Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Lung Cancer Therapeutics Revenue by Company (2020-2022)
6.2 North America Lung Cancer Therapeutics Revenue by Type (2017-2028)
6.3 North America Lung Cancer Therapeutics Revenue by Application (2017-2028)
6.4 North America Lung Cancer Therapeutics Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Lung Cancer Therapeutics Revenue by Company (2020-2022)
7.2 Europe Lung Cancer Therapeutics Revenue by Type (2017-2028)
7.3 Europe Lung Cancer Therapeutics Revenue by Application (2017-2028)
7.4 Europe Lung Cancer Therapeutics Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Lung Cancer Therapeutics Revenue by Company (2020-2022)
8.2 Asia Pacific Lung Cancer Therapeutics Revenue by Type (2017-2028)
8.3 Asia Pacific Lung Cancer Therapeutics Revenue by Application (2017-2028)
8.4 Asia Pacific Lung Cancer Therapeutics Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Lung Cancer Therapeutics Revenue by Company (2020-2022)
9.2 Latin America Lung Cancer Therapeutics Revenue by Type (2017-2028)
9.3 Latin America Lung Cancer Therapeutics Revenue by Application (2017-2028)
9.4 Latin America Lung Cancer Therapeutics Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Lung Cancer Therapeutics Revenue by Company (2020-2022)
10.2 Middle East and Africa Lung Cancer Therapeutics Revenue by Type (2017-2028)
10.3 Middle East and Africa Lung Cancer Therapeutics Revenue by Application (2017-2028)
10.4 Middle East and Africa Lung Cancer Therapeutics Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Lung Cancer Therapeutics Products and Services
11.1.4 AstraZeneca Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.1.5 AstraZeneca Lung Cancer Therapeutics SWOT Analysis
11.1.6 AstraZeneca Recent Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Lung Cancer Therapeutics Products and Services
11.2.4 Eli Lilly and Company Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.2.5 Eli Lilly and Company Lung Cancer Therapeutics SWOT Analysis
11.2.6 Eli Lilly and Company Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Lung Cancer Therapeutics Products and Services
11.3.4 GlaxoSmithKline Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.3.5 GlaxoSmithKline Lung Cancer Therapeutics SWOT Analysis
11.3.6 GlaxoSmithKline Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Lung Cancer Therapeutics Products and Services
11.4.4 Roche Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.4.5 Roche Lung Cancer Therapeutics SWOT Analysis
11.4.6 Roche Recent Developments
11.5 Boehringer Ingelheim GmbH
11.5.1 Boehringer Ingelheim GmbH Company Details
11.5.2 Boehringer Ingelheim GmbH Business Overview
11.5.3 Boehringer Ingelheim GmbH Lung Cancer Therapeutics Products and Services
11.5.4 Boehringer Ingelheim GmbH Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.5.5 Boehringer Ingelheim GmbH Lung Cancer Therapeutics SWOT Analysis
11.5.6 Boehringer Ingelheim GmbH Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Lung Cancer Therapeutics Products and Services
11.6.4 Pfizer Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.6.5 Pfizer Lung Cancer Therapeutics SWOT Analysis
11.6.6 Pfizer Recent Developments
11.7 Sanofi S.A.
11.7.1 Sanofi S.A. Company Details
11.7.2 Sanofi S.A. Business Overview
11.7.3 Sanofi S.A. Lung Cancer Therapeutics Products and Services
11.7.4 Sanofi S.A. Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.7.5 Sanofi S.A. Lung Cancer Therapeutics SWOT Analysis
11.7.6 Sanofi S.A. Recent Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Lung Cancer Therapeutics Products and Services
11.8.4 Bristol-Myers Squibb Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.8.5 Bristol-Myers Squibb Lung Cancer Therapeutics SWOT Analysis
11.8.6 Bristol-Myers Squibb Recent Developments
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Lung Cancer Therapeutics Products and Services
11.9.4 Novartis Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.9.5 Novartis Lung Cancer Therapeutics SWOT Analysis
11.9.6 Novartis Recent Developments
11.10 Agennix AG
11.10.1 Agennix AG Company Details
11.10.2 Agennix AG Business Overview
11.10.3 Agennix AG Lung Cancer Therapeutics Products and Services
11.10.4 Agennix AG Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.10.5 Agennix AG Lung Cancer Therapeutics SWOT Analysis
11.10.6 Agennix AG Recent Developments
12 Lung Cancer Therapeutics Market Dynamics
12.1 Lung Cancer Therapeutics Market Trends
12.2 Lung Cancer Therapeutics Market Drivers
12.3 Lung Cancer Therapeutics Market Challenges
12.4 Lung Cancer Therapeutics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Radiation Therapy
Table 6. Key Players of Others
Table 7. Global Lung Cancer Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Lung Cancer Therapeutics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Lung Cancer Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Lung Cancer Therapeutics Revenue Market Share by Region (2017-2022)
Table 11. Global Lung Cancer Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 12. Global Lung Cancer Therapeutics Market Share by Players (2017-2022)
Table 13. Global Top Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapeutics as of 2021)
Table 14. Ranking of Global Top Lung Cancer Therapeutics Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by Lung Cancer Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players Lung Cancer Therapeutics Product Solution and Service
Table 18. Date of Key Manufacturers Enter into Lung Cancer Therapeutics Market
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 21. Global Lung Cancer Therapeutics Revenue Market Share by Type (2017-2022)
Table 22. Global Lung Cancer Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 23. Global Lung Cancer Therapeutics Revenue Market Share by Type (2023-2028)
Table 24. Global Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 25. Global Lung Cancer Therapeutics Revenue Market Share by Application (2017-2022)
Table 26. Global Lung Cancer Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 27. Global Lung Cancer Therapeutics Revenue Market Share by Application (2023-2028)
Table 28. North America Lung Cancer Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 29. North America Lung Cancer Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 30. North America Lung Cancer Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 31. North America Lung Cancer Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 32. North America Lung Cancer Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 33. North America Lung Cancer Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 34. North America Lung Cancer Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 35. Europe Lung Cancer Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 36. Europe Lung Cancer Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 37. Europe Lung Cancer Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 38. Europe Lung Cancer Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 39. Europe Lung Cancer Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 40. Europe Lung Cancer Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 41. Europe Lung Cancer Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 42. Asia Pacific Lung Cancer Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 43. Asia Pacific Lung Cancer Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Lung Cancer Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Lung Cancer Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Lung Cancer Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Lung Cancer Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Lung Cancer Therapeutics Revenue by Region (2023-2028) & (US$ Million)
Table 49. Latin America Lung Cancer Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 50. Latin America Lung Cancer Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 51. Latin America Lung Cancer Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 52. Latin America Lung Cancer Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 53. Latin America Lung Cancer Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 54. Latin America Lung Cancer Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 55. Latin America Lung Cancer Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Lung Cancer Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 57. Middle East and Africa Lung Cancer Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Lung Cancer Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Lung Cancer Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Lung Cancer Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Lung Cancer Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Lung Cancer Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Lung Cancer Therapeutics Product and Services
Table 66. AstraZeneca Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 67. AstraZeneca Lung Cancer Therapeutics SWOT Analysis
Table 68. AstraZeneca Recent Developments
Table 69. Eli Lilly and Company Company Details
Table 70. Eli Lilly and Company Business Overview
Table 71. Eli Lilly and Company Lung Cancer Therapeutics Product and Services
Table 72. Eli Lilly and Company Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 73. Eli Lilly and Company Lung Cancer Therapeutics SWOT Analysis
Table 74. Eli Lilly and Company Recent Developments
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Lung Cancer Therapeutics Product and Services
Table 78. GlaxoSmithKline Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 79. GlaxoSmithKline Lung Cancer Therapeutics SWOT Analysis
Table 80. GlaxoSmithKline Recent Developments
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Lung Cancer Therapeutics Product and Services
Table 84. Roche Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 85. Roche Lung Cancer Therapeutics SWOT Analysis
Table 86. Roche Recent Developments
Table 87. Boehringer Ingelheim GmbH Company Details
Table 88. Boehringer Ingelheim GmbH Business Overview
Table 89. Boehringer Ingelheim GmbH Lung Cancer Therapeutics Product and Services
Table 90. Boehringer Ingelheim GmbH Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 91. Boehringer Ingelheim GmbH Lung Cancer Therapeutics SWOT Analysis
Table 92. Boehringer Ingelheim GmbH Recent Developments
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Lung Cancer Therapeutics Product and Services
Table 96. Pfizer Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 97. Pfizer Lung Cancer Therapeutics SWOT Analysis
Table 98. Pfizer Recent Developments
Table 99. Sanofi S.A. Company Details
Table 100. Sanofi S.A. Business Overview
Table 101. Sanofi S.A. Lung Cancer Therapeutics Product and Services
Table 102. Sanofi S.A. Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 103. Sanofi S.A. Lung Cancer Therapeutics SWOT Analysis
Table 104. Sanofi S.A. Recent Developments
Table 105. Bristol-Myers Squibb Company Details
Table 106. Bristol-Myers Squibb Business Overview
Table 107. Bristol-Myers Squibb Lung Cancer Therapeutics Product and Services
Table 108. Bristol-Myers Squibb Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 109. Bristol-Myers Squibb Lung Cancer Therapeutics SWOT Analysis
Table 110. Bristol-Myers Squibb Recent Developments
Table 111. Novartis Company Details
Table 112. Novartis Business Overview
Table 113. Novartis Lung Cancer Therapeutics Product and Services
Table 114. Novartis Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 115. Novartis Lung Cancer Therapeutics SWOT Analysis
Table 116. Novartis Recent Developments
Table 117. Agennix AG Company Details
Table 118. Agennix AG Business Overview
Table 119. Agennix AG Lung Cancer Therapeutics Product and Services
Table 120. Agennix AG Lung Cancer Therapeutics Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 121. Agennix AG Lung Cancer Therapeutics SWOT Analysis
Table 122. Agennix AG Recent Developments
Table 123. Lung Cancer Therapeutics Market Trends
Table 124. Lung Cancer Therapeutics Market Drivers
Table 125. Lung Cancer Therapeutics Market Challenges
Table 126. Lung Cancer Therapeutics Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Therapeutics Sales Market Share by Type: 2021 VS 2028
Figure 2. Targeted Therapy Features
Figure 3. Immunotherapy Features
Figure 4. Chemotherapy Features
Figure 5. Radiation Therapy Features
Figure 6. Others Features
Figure 7. Global Lung Cancer Therapeutics Sales Market Share by Application: 2021 VS 2028
Figure 8. Non-Small Cell Lung Cancer (NSCLC) Case Studies
Figure 9. Small Cell Lung Cancer (SCLC) Case Studies
Figure 10. Lung Cancer Therapeutics Report Years Considered
Figure 11. Global Lung Cancer Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Lung Cancer Therapeutics Market Size 2017-2028 (US$ Million)
Figure 13. Global Lung Cancer Therapeutics Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Lung Cancer Therapeutics Revenue Market Share by Region in 2017 VS 2022
Figure 15. Global Top 10 Lung Cancer Therapeutics Countries Ranking by Market Size (US$ Million) in 2021
Figure 16. Global Lung Cancer Therapeutics Market Share by Players in 2021
Figure 17. Global Top Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapeutics as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Lung Cancer Therapeutics Revenue in 2021
Figure 19. North America Lung Cancer Therapeutics Revenue Market Share by Company in 2021
Figure 20. North America Lung Cancer Therapeutics Revenue Market Share by Type (2017-2028)
Figure 21. North America Lung Cancer Therapeutics Revenue Market Share by Application (2017-2028)
Figure 22. North America Lung Cancer Therapeutics Revenue Share by Country (2017-2028)
Figure 23. U.S. Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 24. Canada Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 25. Europe Lung Cancer Therapeutics Revenue Market Share by Company in 2021
Figure 26. Europe Lung Cancer Therapeutics Revenue Market Share by Type (2017-2028)
Figure 27. Europe Lung Cancer Therapeutics Revenue Market Share by Application (2017-2028)
Figure 28. Europe Lung Cancer Therapeutics Revenue Share by Country (2017-2028)
Figure 29. Germany Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 30. France Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 31. U.K. Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 32. Italy Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 33. Russia Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Lung Cancer Therapeutics Revenue Market Share by Company in 2021
Figure 35. Asia Pacific Lung Cancer Therapeutics Revenue Market Share by Type (2017-2028)
Figure 36. Asia Pacific Lung Cancer Therapeutics Revenue Market Share by Application (2017-2028)
Figure 37. Asia Pacific Lung Cancer Therapeutics Revenue Share by Region (2017-2028)
Figure 38. China Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 39. Japan Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 40. South Korea Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 41. India Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 42. Australia Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 43. Taiwan Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 44. Indonesia Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 45. Thailand Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 46. Malaysia Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 47. Philippines Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 48. Vietnam Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 49. Latin America Lung Cancer Therapeutics Revenue Market Share by Company in 2021
Figure 50. Latin America Lung Cancer Therapeutics Revenue Market Share by Type (2017-2028)
Figure 51. Latin America Lung Cancer Therapeutics Revenue Market Share by Application (2017-2028)
Figure 52. Latin America Lung Cancer Therapeutics Revenue Share by Country (2017-2028)
Figure 53. Mexico Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 54. Brazil Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 55. Argentina Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 56. Middle East and Africa Lung Cancer Therapeutics Revenue Market Share by Company in 2021
Figure 57. Middle East and Africa Lung Cancer Therapeutics Revenue Market Share by Type (2017-2028)
Figure 58. Middle East and Africa Lung Cancer Therapeutics Revenue Market Share by Application (2017-2028)
Figure 59. Middle East and Africa Lung Cancer Therapeutics Revenue Share by Country (2017-2028)
Figure 60. Turkey Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 61. Saudi Arabia Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 62. UAE Lung Cancer Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 63. AstraZeneca Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 66. Roche Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 67. Boehringer Ingelheim GmbH Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 68. Pfizer Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 69. Sanofi S.A. Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 70. Bristol-Myers Squibb Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 71. Novartis Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 72. Agennix AG Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs